BRANFORD, CT, UNITED STATES, March 10, 2026 /EINPresswire.com/ -- In recognition of Women’s History Month and the ...

The 3.2T DR8 PIC with 448G EAMs delivers clear benefits in power efficiency, cost, and time to production.”— Dr. Adam ...

Selika Talbott named President of The Transportation Channel, bringing policy and mobility expertise to help expand ...

It seems that for every show at one of Connecticut’s major regional theaters, there’s a unique story about how the cast came together. This is remarkable because in many ways the casting process is ...

Abstract: Due to the large number of connections and the complex variety of connections in three-phase electricity meters, along with some users engaging in electricity theft, three-phase electricity ...

More for You I asked 3 food experts to name the best American cheese—they all said the same brand Germany issues warning to United States amid 'deep rift' Spring outlook is here and a shift is coming: ...

Roche Holdings AG (OTC: RHHBY) on Tuesday released topline results from the CT388-103 Phase 2 trial of CT-388 for obesity. CT-388 is an investigational once-weekly subcutaneous injectable, dual ...

Genentech Announces Positive Phase II Results for Its Dual GLP-1/GIP Receptor Agonist CT-388 in People Living With Obesity - A once-weekly subcutaneous injection of CT-388 achieved a statistically ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. Roche plans to launch Phase 3 studies of its leading obesity candidate ...

- A once-weekly subcutaneous injection of CT-388 achieved a statistically significant placebo-adjusted weight loss of 22.5% (p < 0.001) at 48 weeks at the highest dose tested (24 mg), without reaching ...

The NYT Connections puzzle today is not too difficult to solve if you're a pop music fan. Connections is the one of the most popular New York Times word games that's captured the public's attention.